Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942011000500009
Brazilian Journal of Anesthesiology
Scientific Article

O efeito dos anestésicos inalatórios halotano e sevoflurano em um modelo experimental de lesão hepática

Effects of the inhalational anesthetics halothane and sevoflurane on an experimental model of hepatic injury

Andrea Fogaça Soubhia; Susi Lauz; Edna Frasson de Souza Montero; Alessandro Menezes; Luciane Bicca Mespaque; Emilio Facin

http://dx.doi.org/10.1590/S0034-70942011000500009 Braz J Anesthesiol, vol.61, n5, p.597-603, 2011
PDF Português
PDF English
Downloads: 0
Views: 1031

Resumo

JUSTIFICATIVA E OBJETIVOS: A lesão hepática pós-anestesia inalatória ainda é controversa. Estudos sugerem que agentes inalatórios geram uma resposta imune que pode provocar lesões hepáticas. O objetivo deste estudo é analisar o efeito dos anestésicos inalatórios halotano e sevoflurano no fígado de ratos submetidos à hipóxia e à reperfusão. MÉTODO: Foram utilizados 30 ratos Wistar pré-tratados com fenobarbital 0,1% por cinco dias, com suspensão da medicação 24 horas antes do experimento, a fim de provocar a lesão hepática. Os animais foram distribuídos em cinco grupos com seis ratos cada. O Grupo C foi o de controle, sem qualquer tipo de tratamento; o Grupo F foi aquele no qual se induziu lesão hepática com fenobarbital; o Grupo Hipóxia foi exposto a 14% de oxigênio (O2); o Grupo H recebeu halotano 1% e 14% de O2; e o Grupo S recebeu sevoflurano 2% e 14% de O2. Contadas 24 horas após a exposição dos gases, realizaram-se coletas de sangue para avaliação de transaminases (AST e ALT) e de amostras de fígado para avaliação histológica. Foram usados os testes de Análise de Variância não paramétrica de Kruskal-Wallis e, para comparação de médias, os testes de Newman-Keuls. RESULTADOS: A atividade enzimática revelou que os valores de média amostral de AST (280,33 para halotano, 181 para sevoflurano) e ALT (235 para halotano e 48,33 para sevoflurano) não indicaram diferença estatística significativa; os grupos testados apresentaram valores elevados. O sevoflurano, quando comparado com o halotano à microscopia óptica, apresentou índices menores de alteração morfológica, com p = 0,045 para esteatose, p = 0,0075 para infiltrado inflamatório e p = 0,0074 para necrose. CONCLUSÕES: O Grupo sevoflurano, quando comparado ao Grupo halotano, não apresentou lesão no parênquima hepático quando avaliado por microscopia óptica.

Palavras-chave

ANESTESIA, ANESTÉSICOS, ANESTÉSICOS, ANESTÉSICOS, DOENÇAS

Abstract

BACKGROUND AND OBJECTIVES: Hepatic injury after inhalational anesthesia is controversial. Studies have suggested that inhalational agents generate an immune response that can provoke hepatic injury. The objective of this study was to analyze the effects of the inhalational agents halothane and sevoflurane on the liver of rats submitted to hypoxia and reperfusion. METHODS: Thirty Wistar rats, pretreated with 0.1% phenobarbital for 5 days, with discontinuation of the drug 24 hours before the experiment to cause hepatic injury, were used. Animals were distributed in five groups of six rats each. The control group (C) did not receive any treatment; in the F group, phenobarbital was used to induce hepatic injury; the Hypoxia group was submitted to 14% oxygen (O2); the H group received 1% halothane and 14% O2; and the S group received 2% sevoflurane and 14% O2. Twenty-four hours after exposure to the gases, blood samples were collected to evaluate transaminases (AST and ALT), and liver samples were collected for histological evaluation. Kruskal-Wallis Analysis of Variance and the Newman-Keuls test were used. RESULTS: Enzymatic activity mean values of AST (280.33, for halothane, 181, for sevoflurane) and ALT (235 for halothane, and 48.33, for sevoflurane) did not show significant differences, and all groups showed elevated values. Compared to halothane on optical microscopy, sevoflurane had lower indices of morphologic changes with p = 0.045, for steatosis, p = 0.0075, for inflammatory infiltrate, and p = 0.0074, for necrosis. CONCLUSIONS: Compared to the halothane group, sevoflurane did not show injuries of the liver parenchyma on optical microscopy.

Keywords

Halothane, General Anesthesia, Inhalational Anesthetics, Hepatopathies

Referencias

Powell-Jackson P, Greenway B, William R. Adverse effects of exploratory laparotomy in patients with unsuspected liver disease. Br J Anesth. 1982;69:449-451.

Garrison RN, Cryer HM, Howard DA, Polk Jr HC. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648-655.

McLain GE, Sipes IG, Brown BR Jr. An animal model of halothane hepatotoxicity: roles of enzyme induction of hypoxia. Anesthesiology. 1979;51:321-326.

Shingu K, Eger EI, Johnson BH. Hepatic injury induced by anesthetic agents in rats. Anesth Analg. 1983;62:140-145.

Ray DC, Drumond GB. Halothane hepatitis. Br J Anesth. 1991;67:84-99.

Martin J, Dubbink DA, Plevak DJ. Halothane hepatitis 28 years after primary exposure. Anesth Analgesia. 1992;74:605-608.

Fassoulaki A, Eger EI 2nd, Johnson B. Brief periods of hypoxia can produce hepatic injury in rats. Anesth Analg. 1984;63:885-887.

Mets B, James M, James MF, Hickman R. Hepatic energy charge and adenine nucleotide status in rats anesthetized with halothane, isoflurane or enflurane. Acta Anesth Scand. 1997;41:252-255.

Njoku D, Laster M, Eger E. Biotransformation of halothane, enflurane, isoflurane and desflurane to trifluoroacetylated liver protein: association between protein acylation and hepatic injury. Anesth Analg. 1997;84:173-178.

Soma LR, Tierney WJ, Hogan GK, Satoh N. The effects of multiple administrations of sevoflurane to monkeys: clinical pathologic, hematologic and pathologic study. Anesth Analg. 1995;81:347-352.

Kharasch ED. Metabolism and toxicity of the new anesthetic agents. Acta Anesthesiol Belg. 1996;47:7-14.

Frink EJ. The hepatic effects of sevoflurane. Anesth Analgesia. 1995;81:46-50.

Brasil LJ, Amaral JL, Zettler CG, Marroni CA, Vercelino R, Marroni N. Modelo experimental de indução de lesão oxidativa hepática em ratos por halotano. Arq Gastroenterol. 2007;44:45-51.

Nagata R, Sameschima H, Komaki T. The effects of inhalation of sevoflurane for an hour on the liver of beagles. Jap J Anesth. 1991;40:887-895.

Wallin RF, Regan BM, Napoli MD, Stern IJ. Sevoflurane: a new inhalation anesthetic agent. Anesth Analgesia. 1975;54:758-766.

5dd6a0fc0e88257f2113f288 rba Articles
Links & Downloads
2352-2291 (Electrónico) 0104-0014 (Impreso)
Braz J Anesthesiol ©2024 Todos los derechos reservados.

Braz J Anesthesiol

Share this page
Page Sections